America January 30, 2026
AstraZeneca China Obesity Drug Deal Worth Up to $18.5B
Biotechnology powerhouse AstraZeneca has inked a landmark licensing agreement with China’s CSPC Pharmaceutical Group Ltd., potentially worth $18.5 billion, aimed…
America January 30, 2026
Biotechnology powerhouse AstraZeneca has inked a landmark licensing agreement with China’s CSPC Pharmaceutical Group Ltd., potentially worth $18.5 billion, aimed…
By Rihem Akkouche
America November 24, 2025
Clearside Biomedical, a clinical-stage company specializing in eye-disease treatments, has filed for Chapter 11 bankruptcy in Delaware, launching a high-stakes…
By Rihem Akkouche
America October 11, 2025
In a bold leap into the next era of medical innovation, Bristol Myers Squibb announced Friday it will acquire Orbital…
By Rihem Akkouche
America October 1, 2025
Biopharmaceutical heavyweight Halozyme Therapeutics Inc. announced Wednesday it will acquire fellow biotech innovator Elektrofi Inc. in a deal valued at…
By Rihem Akkouche
America September 22, 2025
In a dramatic turn, ProPhase Labs Inc. placed three of its affiliates into Chapter 11 bankruptcy protection Monday in New…
By Rihem Akkouche
America September 16, 2025
In a high-stakes move that could reshape emergency medicine, global biotech giant CSL has struck an exclusive option agreement to…
By Rihem Akkouche
America September 15, 2025
In a bold wager on next-generation drug discovery, Novartis, Monte Rosa $5.7B Deal is set to reshape the landscape of…
By Rihem Akkouche
America September 9, 2025
Novartis AG said Tuesday it has agreed to acquire Tourmaline Bio Inc. in a $1.4 billion all-cash deal, a bold…
By Rihem Akkouche
America August 25, 2025
AbbVie Inc., advised by Covington & Burling LLP, has announced a blockbuster acquisition of Gilgamesh Pharmaceuticals’ lead psychedelic therapy candidate,…
By Rihem Akkouche
America July 18, 2025
In a blockbuster pharma merger that shook the global biotech sector, Sanofi announced Friday it has officially completed its acquisition…
By Rihem Akkouche